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Objectives. This study evaluated the role of neutrophil adhesion 
molecules LFA-1 (CDlla/CD18), Mac-1 (CDllb/CD18) and 
p150,95 (CDllc/CD18) in patients undergoing percutaneous 
transluminal coronary angioplasty (PTCA). 
Background. Several recent studies have suggested that cell 
adhesion molecules on both neutrophils and vascular endothelial 
cells play an important role in the process of tissue inflammation. 
Methods. Thirty-eight patients (30 men, 8 women; mean [--. SE] 
age 56 +- 5 years, range 38 to 76) with single.vessel coronary artery 
disease of the left anterior descending artery underwent coronary 
angioplasty. Peripheral blood was sampled at baseline before, 
immediately after and 12, 24, 48 and 144 h after PTCA. The 
expression of CD18, CDIla, CDIlb and CDllc on the surface of 
polymorphonuclear leukocytes was examined by flow cytometry 
with monoclonal ntibodies. 
Results. In patients without subsequent restenosis, there was 
no change in mean channel fluorescence intensity (MFI) of CD18 
at each sampling time. However, in the patients with restenosis, 
the MFI of CD18 significantly increased at 48 h after PTCA (from 
57 + 6 to 73 + 8, p = 0.0008). The MFI of CDllb increased 
slightly at 48 h after PTCA in patients without restenosis (from 
584 -+ 121 to 735 -+ 114, p = 0.037). In patients with restenosis, 
the MFI of CDllb was slightly increased at 24 h after PTCA (from 
586 -+ 122 to 768 -+ 214, p = 0.018) and significantly increased at 
48 h after PTCA (to 1,534 -+ 268, p = 0.0006). The expression of 
CDlla and CDllc did not change at any sampling points after 
PTCA in either of the two patient groups. Percent change in the 
expression of CD18 at 48 h after PTCA (from baseline) and that 
of CDllb were correlated (r = 0.73, p = 0.0008) in patients with 
restenosis. 
Conclusions. Inflammatory stimuli within the coronary vessels 
associated with coronary angioplasty may upregulate Mac-1 ex- 
pression on the surface of polymorphonuclear leukocytes. This 
process may be more marked in patients who experience later 
restenosis. Thus, activation of neutrophil adhesion molecule 
Mac-1 at 48 h after PTCA may have value as a predictor of 
subsequent restenosis. 
(J Am Coil Cardiol 1996;28:1127-33) 
Polymorphonuclear leukocytes migrate across the vascular 
endothelium into the extravascular space in response to tissue 
injury and inflammation (1). Leukocyte adhesion to vascular 
endothelial cells is an important step in this process (2). It has 
been shown (3,4) that this adhesion is mediated by adhesion 
molecules, which are expressed on the cell surface. They induce 
various cell-cell interactions as receptor-ligand relations (3,4). 
The neutrophil adhesion molecules include a family of 
heterodimic glycoproteins (called beta2-integrins ) possessing a 
common beta-subunit of CD18 associated noncovalently with 
separate alpha-subunits of CDlla, CDIlb and CDllc, and 
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designated as LFA-1, Mac-1 and p150,95, respectively (5-7). 
The adhesion molecules normally exist on the surface of 
neutrophils. However, inflammatory stimuli produce an in- 
crease in the cell surface xpression of these molecules (8,9). 
Endothelial cell surface molecules, including C3bi, derived 
from the activation of the complement system, and intercellu- 
lar adhesion molecule-1 (ICAM-1), interact with neutrophil 
CD18 adhesion-promoting receptor (5-7). The neutrophils 
adhere to endothelial cells and when activated can release a 
variety of mediators capable of promoting tissue injury. 
Percutaneous transluminal coronary angioplasty (PTCA) is 
an established treatment for patients with coronary artery 
disease. Although PTCA has a high initial success rate, resten- 
osis remains amajor problem limiting the long-term efficacy of 
the procedure (10-12). The mechanism of restenosis has not 
been fully understood. Several investigators (13-15) have 
suggested that neutrophils might play a part in the mechanism 
of this rcstenosis. Coronary angioplasty induces neutrophil 
activation, which results in the release of various inflammatory 
mediators that may potentiate development of smooth muscle 
cell proliferation and resulting restenosis (13-15). 
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Acronyms and Abbreviations 
ICAM-1 = intercellular adhesion molecule-I 
IL-1 - interleukin-1 
MFI - mean channel fluorescence intensity 
PTCA - percutaneous transluminal coronary angioplasty 
TNF-alpha - tumor necrosis factor-alpha 
The present study sought o determine the role of leukocyte 
adhesion molecules LFA-1 (CD11a/CD18), Mac-1 (CDllb/ 
CD18) and p150,95 (CD11c/CD18) in patients undergoing 
PTCA. 
Methods  
Patients. Thirty-eight patients (30 men, 8 women; mean 
[+SEM] age 56 + 5 years, range 38 to 76) who underwent 
initial elective PTCA were enrolled in the study. They all had 
isolated atherosclerotic coronary artery disease (->75% diam- 
eter stenosis) of the proximal eft anterior descending artery. 
All patients had clinically stable angina pectoris without pre- 
vious myocardial infarction and had evidence of ischemia 
evaluated by exercise stress electrocardiography and thallium- 
201 myocardial scintigraphy. All patients received the standard 
medication for angina, including 40 mg of isosorbide dinitrate, 
40 mg of nifedipine, 81 mg of aspirin and 75 mg of dipyridam- 
ole daily, and none of these drugs was discontinued before 
PTCA. Exclusion criteria included receipt of other cardioac- 
tive drugs and the presence of other cardiac or noncardiac 
complications that could affect our analysis. Seven healthy 
volunteers (five men, two women; mean age 49 + 7 years, 
range 32 to 72) were also studied as control subjects. The study 
protocol was approved by the Dokkyo University Institutional 
Review Board, and written informed consent was obtained 
from each patient. 
Percutaneous transluminal coronary angioplasty. Coro- 
nary angioplasty was performed using the standard Judkins 
technique and a movable guide wire system through the 
femoral artery. An 8F guiding catheter (USCI, Inc.) was 
positioned in the coronary ostium, and control coronary an° 
giograms were obtained. All patients received premedication 
with 5,000 U of intravenous heparin and 0.1 mg of intracoro- 
nary nitroglycerin before angiography. The dilation procedure 
was performed with multiple balloon inflations using steerable 
nonperfusion balloon dilation catheters (USCI, Inc.) ranging 
in diameter f om 2.5 to 3.5 mm when inflated. Optimal balloon 
sizes were chosen on the basis of estimates of reference 
diameter of normal segments adjacent o the lesion. Each 
balloon inflation was maintained for 90 s at a pressure range 
from 6 to 12 atm. A nonionic iodinated contrast agent was used 
during the procedure (Iopamidole, Schering AG) in all pa- 
tients. After PTCA, all patients received 500 U/h of intrave- 
nous heparin for 24 h. Any oral medications were not changed 
until follow-up angiography. Follow-up angiography was rec- 
ommended to all patients at 6 months after PTCA and was 
performed earlier if there were clinical indications. Coronary 
lesions were assessed angiographically before and immediately 
after PTCA and at follow-up coronary angiography. The 
method used, caliper measurements in multiple projections, 
adequately demonstrated the lesions. Primary success of an- 
gioplasty was defined as a 20% increase in lumen diameter and 
a residual diameter stenosis <50%. For purposes of follow-up 
angiography, restenosis was defined as >50% diameter steno- 
sis. 
Flow cytometric analysis of leukocyte adhesion molecules. 
In each patient, peripheral blood was sampled at baseline 
before, immediately after and 12, 24, 48 and 144 h after PTCA. 
Blood samples were also obtained from the healthy volunteers. 
The expression of CD18, CDlla, CD11b and CDllc on the 
surface of polymorphonuclear leukocytes was analyzed by flow 
cytometry with monoclonal antibodies. Blood was immediately 
collected in a tube containing acid citrate dextrose (ACD). 
Two-color immunofluorescence staining (16) was performed 
using fluorescein isothiocyanate (FITC) (17) conjugated anti- 
CD18 (IOY18, Immunotech, Inc.) and anti-CDlla (IOT16, 
Immunotech, Inc.) and phycoerythrin (PE) (18) conjugated 
anti-CDllb (Lew 15, Becton Dickinson) and anti-CDllc 
(LewM5, Becton Dickinson). After hemolysis was completed 
by the lysing solution, cells were fixed in a paraformaldehyde 
solution with phosphate-buffered saline (PBS). The staining 
process was performed according to the National Committee 
for Clinical Laboratory Standards guidelines for flow cytom- 
etry (19). Two-color flow cytometric analysis was then per- 
formed using a FACScan laser flow cytometry system (Becton 
Dickinson) within 2 h. We collected the data from 10,000 
cells/test and analyzed the scatter signals and fluorescence 
intensity. The light-scattering properties projected on a scat- 
tergram could distinguish the polymorphonuclear leukocyte 
cluster from other leukocyte clusters (20). Fluorescence inten- 
sity was expressed on a cytohistogram where the region of 
interest was limited to the polymorphonuclear leukocyte clus- 
ter for CD18, CDlla, CDllb, and CDllc each. Mean channel 
fluorescence intensity (MFI) (21) was calculated as the index 
of the expression of each adhesion molecule. 
Data analysis. Coronary angiograms were assessed by two 
independent observers (T.I., Y.S.). Each observer measured 
the severity of stenosis using the same technique, and the mean 
value was recorded. There was a 1.8 _+ 5.7% difference 
between the two observers on 30 randomly selected lesions, 
excluding those of the study patients. Serial changes in the MFI 
of CD18, CD1 la, CD1 lb and CDllc were each analyzed using 
repeated measures analysis of variance in patients with and 
without restenosis for intragroup and intergroup comparisons. 
Comparisons of the values between the two patient groups and 
the control subjects were performed using one-way analysis of 
variance. The chi-square test or unpaired t test was used for 
intergroup comparisons ofbaseline characteristics. Correlation 
between percent increase in the MFI of CD18 and that of 
CD1 lb was determined with linear regression in each patient 
group. To predict he occurrence of restenosis, the sensitivity 
of increases in the MFI of CD18 or CDllb, or both, was 
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Table 1. Clinical Characteristics of 38 Study Patients 
Pts Without Pts With 
Restenosis Restenosis 
(n - 24) (n = 14) p Value 
Age 55 + 4 57 ± 3 0.366 
Men/'women (no.) 19/5 11/3 0.284 
Leukocyte count (//xl) 6.760 _+ 360 6,270 _- 290 0.226 
Platelet count (x 104/,al) 28.5 _+ 4.6 30.2 _~ 5.8 0.183 
PT (s) 11.2 + 0.3 11.3 = 0.2 0.676 
APTI" (s) 31.6 _+ 0.6 31.9 = 0.5 0.720 
Corona U risk factors 
Cigarette smoking 21 (88%) 12 (86%) 0.624 
Family history. 7 (29c2) 4 (28%) 0.641 
Diabetes mellitus 4 (17C~-) 2 (14%) 0.528 
Systemic hypertension 7 (29c; ~) 4 (28%) 0.725 
Total cholesterol (mg/dl) 
Before PTCA 207 " 9 214 -- 12 0.465 
At follow-up study 197 + 8 199 + 14 0.673 
HDL cholesterol (mg/dl) 
Before PTCA 37 _+ 2 36 _+ 2 0.322 
At follow-up study 39 _+ 4 39 _+ 3 0.864 
Taking lipid-lowering drugs 4 (17%) 2 (14%) 0.464 
Data presented are mean " SE or number (%) of patients (Pts). APTT - 
activated partial thromboplastin time; HDL high density lipoprotein; PT - 
prothrombin time: PTCA - percutaneous transluminal coronau, angioplasty. 
determined as true positive/(true positive + false negative), 
specificity as true negative/(true negative + false positive), 
positive predictive values as true positive/(true positive + false 
positive) and negative predictive values as true negative/(true 
negative + false negative). Results are expressed as mean 
value +__ SE; p < 0.05 was considered significant. 
Results 
Results of angioplasty. Balloon inflations ranged from 
three to eight (mean 4.2 _+ 0.3), and PTCA was initially 
successful in all patients. No patient experienced ither abrupt 
coronary occlusion or major coronary dissection. However, 
restenosis was seen in 14 patients at follow-up angiography. 
Comparison of 24 patients without restenosis and 14 with 
restenosis revealed no significant differences in age, gender, 
leukocyte counts, platelet counts and blood coagulation activ- 
ity before PTCA. There were also no significant differences 
among the patients with regard to coronary risk factors, such as 
smoking habits, family history, diabetes mellitus, hypertension 
and hyperlipidemia (Table 1). Characteristics of coronary 
lesions, including reference diameter, American College of 
Cardiology/American Heart Association classification of lesion 
type, American Heart Association classification of lesion loca- 
tion and severity of stenosis before and immediately after 
PTCA, were similar in patients with and without restenosis. 
Furthermore, there were no significant differences between 
patients with and without restenosis with regard to the angio- 
plasty procedure itself (balloon size, number of inflations, 
inflation pressures, duration of inflations, duration of the 
procedure and amount of contrast medium used). In patients 
with restenosis, time to follow-up study after PTCA was 4.8 + 
1.1 months, possibly indicating the interval after PTCA when 
restenosis was first clinically demonstrable, whereas it was 
6.6 _+ 0.4 months (p = 0.045) in patients without restenosis 
(Table 2). 
Expression of leukocyte adhesion molecules. Serial 
changes in adhesion molecule xpression i patients with and 
without restenosis compared with control values are shown in 
Figure 1. The MFI for CD18 at each sampling time did not 
change immediately or12, 24 or 48 h after PTCA from baseline 
values in patients without restenosis. However, in patients with 
restenosis, it significantly increased at 48 h after PTCA (from 
57 ___ 6 to 73 _ 8, p = 0.0008). The MFI for CDllb increased 
slightly at 48 h after PTCA even in patients without restenosis 
(from 584 -- 121 to 735 -- 114, p = 0.037). In the restenosis 
group, the MFI for CDllb increased slightly at 24 h after 
PTCA (from 586 _+ 122 to 768 : 214, p - 0.018) and increased 
significantly at 48 h after PTCA (to 1,534 _+ 268, p = 0.0006). 
The expression of CDlla and CDllc in both patient groups 
did not change at any sampling time. A comparison of patients 
with and without restenosis at each sampling time reveals that 
there were no significant differences in MFI values, except that 
for CD1 lb at 48 h after PTCA, which was slightly higher (p = 
0.021) in patients with restenosis. A comparison of each 
patient group versus control values hows no significant differ- 
ence, except for the MFI for CD18 (p = 0.046) and CDllb 
(p = 0.009) at 48 h after PTCA, which were higher in patients 
with restenosis. 
Figure 2 shows a correlation between the percent change in 
expression at 48 h after PTCA from the baseline value of CD18 
and CDllb in each patient. Both changes were correlated in 
patients with (r -- 0.73, p = 0.0008) but not in those without 
(r = 0.17, p = 0.382) restenosis. This relation also showed that 
the increase in expression of both CD18 and CDllb at 48 h 
Table 2. Profiles of Coronau, Lesions and Angioplasty Procedure in
38 Study Patients 
Pts Without Pts With 
Restenosis Restenosis 
(n - 24) (n - 14) p Value 
Reference diameter (ram) 2.82 + 0.07 2.79 + 0.06 0.322 
ACC/AHA lesion type (A/B) 14/10 8/6 0.283 
AHA lesion location (seg 6/seg 7) 10/14 7/7 0.128 
% diameter stenosis 
Pre-PTCA 86.9 _+ 3.4 85.2 + 2.8 0.267 
Post-PTCA 14.0 _+ 2.5 15.6 + 3.2 0.324 
Follow-up study 36.5 _+ 4.2 64.8 ± 8.6 0.0003 
Final balloon size (mm) 2.91 _+ 0.07 2.89 + 0.08 0.362 
No. of inflation trials (times) 4.1 - 0.3 4.2 _+ 0.4 0.456 
Peak inflation pressure latin) 11.2 _- 0.3 11.1 -+ 0.2 0.867 
Duration of total inflations (s) 368 _+ 27 382 + 36 0.572 
Duration of all procedures (rain) 56 + 3 59 ± 3 0.120 
Amount of contrast medium (ml) 148 + 7 152 _+ 9 11.261 
Follow-up term (mo) 6.6 _+ 0.4 4.8 ± 1.1 0.045 
Data presented are mean value + SlY or number of lesions. ACC - 
American College of Cardiology; AHA - American Heart Association; seg = 
segment: other abbreviations a  in Table 1. 
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Figure L Serial changes ofeach leukocyte adhesion molecule expres- 
sion evaluated separately in patients with and without restenosis 
compared with control values. See Results for details. 
was greater in patients with restenosis. In our analysis of 
percent change in CD18 at 48 h after PTCA, a threshold value 
of 1.2 had a sensitivity of 86%, a specificity of 83%, a positive 
predictive value of 75% and a negative predictive value of 
91%. For analysis of the percent change in CDllb, a threshold 
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value of 1.7 had a sensitivity of 79%, a specificity of 88%, a 
positive predictive value of 79% and a negative predictive 
value of 88%. Furthermore, for both a >l.2-fold increase in 
expression of CD18 and a >1.7-fold increase in that of CDllb, 
the sensitivity, specificity and positive and negative predictive 
values were 71%, 100%, 100% and 86%, respectively. 
Discussion 
In our study, only patients with single-vessel coronary artery 
disease of the proximal eft anterior descending artery were 
selected for inclusion. All patients had stable angina and no 
previous myocardial infarction, and all were given identical 
medications during the postprocedural period. We demon- 
strated that the expression of CD18 and CDllb on the surface 
of polymorphonuclear leukocytes ampled from peripheral 
blood increased at 48 h after PTCA, whereas expression of 
CDlla and CDllc did not. Increases in the expression of 
CD18 and CD1 lb at 48 h after PTCA were more prominent in
patients with restenosis group despite the finding that baseline 
characteristics (including invasive procedure, coronary risk 
factors and leukocyte count) were similar between patients 
with and without restenosis. Furthermore, the relation be- 
tween both increases in CD18 and CDllb shown in the 
restenosis group indicates that the increase in CD18 expression 
might correspond to the increase in Mac-1. These results 
suggest hat the repeated balloon inflations during PTCA 
resulted in an upregulation of Mac-1 on the surface of 
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polymorphonuclear leukocytes at 48 h after PTCA that might 
be related to the development of restenosis. Moreover, the 
upregulation of Mac-I at 48 h after PTCA had a high 
predictive value for subsequent restenosis. 
Expression of neutrophii adhesion molecules as a marker 
for inflammation. It is widely recognized that adhesion mol- 
ecules CD18, CDlla, CDllb and CDllc are expressed on the 
surface of circulatory neutrophils even under normal condi- 
tions and can be upregulated severalfold by inflammatory 
stimuli using various cytokines, including tumor necrosis 
factor-alpha (TNF-alpha), interleukin-1 (IL-1) or endotoxins 
(8,9). In our study, no significant differences were seen in MFI 
values of the adhesion molecules in patients with and without 
restenosis at any time point or in these patients compared with 
control subjects, except for the values of CD18 and CDllb at 
48 h after PTCA. These values showed large individual varia- 
tions not only in the patient groups but also among the control 
subjects. However, serial changes in an individual are sugges- 
tive of greater significance, and the findings that the values of 
CD18 and CDllb increased at 48 h after PTCA in patients 
with restenosis might be of value. 
Recently, neutrophil adhesion molecules LFA-1, Mac-1 or 
p150,95, alone or in combination, have been postulated to play 
a role in myocardial reperfusion injury (22-27). Endothelial 
injury secondary to ischemia and reperfusion promotes neu- 
trophil adherence to the endothelial cell surface of the post- 
capillary venules. However, these phenomena have been rec- 
ognized mainly in experimental studies with animals, and the 
role of adhesion molecules in the human heart remains 
controversial. Our data suggest hat leukocyte adhesion mole- 
cules may also have a significant impact on the human heart. 
Restenosis after coronary angioplasty. Restenosis is the 
major limitation to the long-term success of PTCA. Restenosis 
occurs within several months of the procedure in approxi- 
mately one-third of patients (10-12). The pathophysiology of 
restenosis has been controversial, but several histopathologic 
studies indicate that intimal proliferation of smooth muscle 
cells is a major mechanism (28). Traumatic injury of the vessel 
wall during angioplasty probably triggers a series of cellular 
and subcellular events that may ultimately lead to myointimal 
proliferation and restenosis. Although the exact mechanism by 
which this occurs is unknown, several factors may enhance 
smooth muscle cell growth and therefore play a role in the 
development of restenosis. These include platelet deposition, 
mechanical stretching of the media; inflammation of the vessel 
wall; the activity of growth factors, such as platelet-derived 
growth factor (PDGF) and basic fibroblast growth factor 
(bFGF); vasoactive substances, uch as serotonin and throm- 
boxane A2; wall shear stress; alterations in vessel geometry; 
and other, still unknown factors (29,30). Leukocyte function 
has recently been singled out for its role in smooth muscle cell 
proliferation. In addition to production of various growth 
factors by macrophages (31), activated neutrophils have been 
also implicated in platelet activation and smooth muscle cell 
proliferation (13-15,32). 
Role of neutrophils in mechanism of restenosis. Coronary 
angioplasty induces neutrophil activation, which results in the 
release of a variety of inflammatory mediators, for example, 
granulocyte proteases, uch as elastase, and superoxide anion 
(14,15). The release of proteolytic enzymes and the generation 
of oxygen free radicals may aggravate the endothelial damage 
and further stimulate platelets. This process has potential 
implications in the subsequent development of smooth muscle 
cell proliferation and resulting restenosis. During the process 
of neutrophil activation, the adhesion of neutrophils to vascu- 
lar endothelial cells is an important physiologic interaction. 
Thus, it is suggested that the adhesion molecules on the 
surface of both neutrophils and endothelial cells may play a 
role in the mechanisms of restenosis. 
Two possible mechanisms explain how PTCA induces the 
upregulation of Mac-l: 1) This process may result from 
ischemia-reperfusion cycles induced by repeated balloon in- 
flations; 2) the traumatic vascular injury by balloon inflation 
may result in this upregulation. Although neutrophil activation 
may be triggered by 15 rain of ischemia followed by reperfusion 
(22), it is not known whether epeated but shorter bouts of 
ischemia followed by restoration of flow, as occurs during 
PTCA, could have the same effects. Mazzone et al. (33) 
observed increased expression of adhesion molecules CD18 
and CDllb on the surface of neutrophils taken from the 
coronary sinus in patients with unstable angina. They specu- 
lated that plaque rupture and subsequent inflammation asso- 
ciated with considerable coronary vascular damage in unstable 
angina might increase the expression of these molecules. In 
line with their suggestion, the traumatic vascular injury may be 
the more important factor. In our study, it would appear that 
inflammatory stimuli within the coronary vessels attributable 
to coronary angioplasty may upregulate Mac-1 expression on 
the surface of polymorphonuclear leukocytes. Therefore, the 
upregulation of Mac-1 may be an indicator of injury or 
inflammation within the vessel. 
Ikeda et al. (34) observed that neutrophil surface expres- 
sion of CDI lb in the coronary sinus blood increased immedi- 
ately after PTCA. In that report, however, the expression was 
evaluated immediately after PTCA only, whereas our study 
showed an increase at 48 h after PTCA. We cannot explain why 
upregulation occurred only at 48 h after the procedure. We 
believe that the magnitude of inflammatory stimuli may be 
related to the duration of leukocyte activation and that ex vivo 
stimuli using cytokines or endotoxins produced immediate 
upregulation of Mac-1 on the surface of leukocytes. In con- 
trast, Tanaka et al. (35) observed the expression of ICAM-1, a 
counterreceptor of LFA-1 and Mac-l, on the endothelial cell 
surface of rabbit aorta 48 h after balloon injury. Prescott et al. 
(32) observed that neutrophils adhered to endothelium at 48 h 
after inducing leukocyte migration by the implantation of an 
endotoxin-soaked cotton thread in the adventitia of the rat 
femoral artery. If the nature of inflammatory stimuli produced 
by PTCA angioplasty in humans is similar to that seen in those 
experiments, our results at 48 h may be understandable. In 
addition, in view of the short life expectancy of the polymor- 
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phonuclear leukocyte, it is likely that PTCA creates a persis- 
tent proinflammatory surface within the artery that can stim- 
ulate leukocyte xpression of Mac-1 for 2 days or that the 
section of artery traumatized bythe balloon inflations begins to 
secrete cytokines uch as TNF-alpha or IL-1 -24 to 36 h after 
the procedure, which can upregulate surface expression of 
Mac-1. The same cytokines that stimulate xpression of the 
leukocyte adhesion molecules may also stimulate smooth 
muscle cell proliferation (36). 
In contrast, he study by Ikeda et al. (34) did not indicate a
direct relation between CDllb expression and the progression 
of restenosis. To our knowledge, our study is the first to 
demonstrate hat the upregulation of Mac-1 is significantly 
greater in patients with than without restenosis. Although our 
study does not necessarily prove that this upregulation has a 
direct role in the mechanism of restenosis, it does suggest some 
relation between this finding and the pathogenesis of resteno- 
sis. Moreover, our results also suggest that activation of the 
polymorphonuclear leukocyte Mac-1 at 48 h after PTCA may 
have value as a predictor of subsequent restenosis. 
Potential limitations. Our study has several possible limi- 
tations. Although we showed that the observed increase in 
CD18 and CDllb had high predictive values for the occur- 
rence of restenosis, these data were analyzed only retrospec- 
tively. Another prospective trial to validate this prediction 
should be considered. In our study, coronary lesions were 
assessed angiographically using only caliper measurements. In 
light of recent progression of quantitative coronary angio- 
graphic analysis, we would need to interpret he relation 
between leukocyte function and quantitative coronary angio- 
graphic data. 
In addition, the expression of leukocyte adhesion molecules 
in our study may have been modified by invasive procedures, 
such as arterial puncture or coronary artery catheterization. 
The introduction of infusion materials, such as contrast me- 
dium (37) or heparin (38), might also influence leukocyte 
function. However, there may still be significance inthe finding 
that serial patterns for the expression of CD18 and CDllb 
were different in patient groups with and without restenosis 
because these groups were similar in terms of the invasive 
procedures performed, amount of contrast medium used and 
dose and duration of heparin. 
Clinical implications. Our study demonstrated that the 
expression of CD18 and CD1 lb on the surface of polymorpho- 
nuclear leukocytes sampled from peripheral blood increased at 
48 h after PTCA. Inflammatory stimuli within the coronary 
vessels, which may be attributable to repeated short-term 
ischemia-reperfusion cycles or traumatic vascular injury asso- 
ciated with the angioplasty, or both, may upregulate Mac-1 on 
the surface of polymorphonuclear leukocytes. This process 
may be more pronounced in patients who experience later 
restenosis. Thus, the upregulation of polymorphonuclear leu- 
kocyte Mac-1 at 48 h after PTCA may have value as a predictor 
of restenosis. 
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